Facebook
Twitter
LinkedIn
Forward
Join Maggie M. Hodges, MD, MPH, for a surgeon's perspective on the role of cancer risk reduction through bariatric surgery, while also exploring the optimal timing of bariatric surgery in patients with a personal history of cancer.
|
Innovations in breast oncology can translate to improved patient outcomes for patients with early and late-stage disease. In this webinar, Dr. Ray will discuss the latest research findings and how they can be translated into the clinical care of patients with breast cancer.
|
Oral oncolytics have revolutionized cancer care over the last two decades. Although they provide a more convenient & often more tolerable alternative to traditional chemotherapy agents, their unique mechanisms of action lead to a wide range of potential side effects. In this CPP panel discussion, Aimee Faso, Bianka Patel, and Kevin Chen will discuss the considerations when managing side effects for patients receiving oral oncolytic treatments for various solid tumor and hematologic malignancies.
|
Ashley Weiner, MD, PhD, presents on the role of radiotherapy for small-cell lung cancer. She provides overview of radiation oncology, and a walk through a patient's pathway from initial consultation with a radiation oncologist to treatment and follow-up. Finally, she reviews the indications for, logistics of, and side effects of radiation for the treatment of small cell lung cancer (limited and extensive stage).
|
Joe Polich, MSW, LCSWA, JD will provide a foundational knowledge to providers who come in contact with patients with cancer who are also experiencing IPV. Beginning with a quick introduction to some basic concepts of the dynamics of IPV in general, we will discuss the intersection of the provision of care to a patient with cancer and the dynamics involved in IPV.
|
Natalie Grover, MD, will review some of the recent advances in the treatment of lymphoma, including the incorporation of novel targeted agents in the frontline treatment of diffuse large B cell lymphoma and Hodgkin lymphoma, the use of CAR-T cell therapy in second-line treatment in diffuse large B cell lymphoma, and recently approved drugs by the FDA for lymphoma.
|
Lauren Lux, MSW and Melissa Matson, MSN, RN, AGPCNP-BC and Catharine Swift, MSW, LCSW highlight tools and strategies that healthcare providers can deploy to meet the medical and psychosocial needs of the AYAs in their care.
|
Mark Woodcock gives a broad overview of the multidisciplinary approaches for the treatment of soft tissue sarcomas in adults, and detailed updates in management with systemic therapies. Specific attention is paid to sarcoma sub-types which may warrant special considerations.
|
Hung-Jui Tan, MD, MSHPM, will review recent practice-changing research and new management recommendations for patients with prostate, kidney, bladder, and testicular cancer.
|
Marc Bjurlin, DO, MSc, FACOS, gives a contemporary overview of prostate cancer screening with a focus on prostate cancer in men in North Carolina.
|